APA (7th ed.) Citation

I, C., M, R., SG, F., A, B., D, A., MG, T., . . . S, S. (2025). ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry"). Rheumatology (Oxford, England), 64(5), 2862. https://doi.org/10.1093/rheumatology/keae583

Chicago Style (17th ed.) Citation

I, Cecchi, et al. "ANA-positive Versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")." Rheumatology (Oxford, England) 64, no. 5 (2025): 2862. https://doi.org/10.1093/rheumatology/keae583.

MLA (9th ed.) Citation

I, Cecchi, et al. "ANA-positive Versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")." Rheumatology (Oxford, England), vol. 64, no. 5, 2025, p. 2862, https://doi.org/10.1093/rheumatology/keae583.